Starpharma Holdings reported AUD3.13M in Selling and Administration Expenses for its fiscal semester ending in December of 2024.


Selling And Administration Expenses Change Date
Medical Developments International AUD 12.94M 5.87M Dec/2024
Mesoblast 12.14M 662K Jun/2024
Neuren Pharmaceuticals AUD 2.33M 47K Dec/2024